Revenue Update on Aralez Pharmaceuticals Inc. – Common Shares(NASDAQ:ARLZ)

Aralez Pharmaceuticals Inc. – Common Shares(NASDAQ:ARLZ) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during Pre-market on Aug 9, 2016. Earnings per share were $-0.27.

Several Insider Transactions has been reported to the SEC. On May 23, 2016, James Patrick Tursi (Chief Medical Officer) purchased 10,000 shares at $3.75 per share price.Also, On May 18, 2016, Mark A Glickman (Chief Commercial Officer) purchased 25,000 shares at $3.68 per share price.On May 18, 2016, Eric Trachtenberg (GC, CCO & Secretary) purchased 10,000 shares at $3.76 per share price, according to the Form-4 filing with the securities and exchange commission.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *